MWV Healthcare Completes Industrialisation Of PFP N

MeadWestvaco (MWV) has completed a year-long validation and industrialisation capital program for its line of preservative-free nasal pumps, the PFP N. It is available in outputs ranging from 0.05ml to 0.14ml.

The company has said that PFP N joins MWV Healthcare’s line of successful pharmaceutical packaging products designed to improve the consumer experience and maximise supply chain efficiencies.

Reportedly, MWV has developed the PFP N to address demand for delivery systems that protect preservative-free drugs from contamination. MWV’s proprietary technology enables the pump to be completely preservative-free while providing shelf life similar to traditional formulations.

The company has claimed PFP N does not use a silver or metal coil for sterilisation, which can have a negative interaction with the drug formula.

Rolf Kitiratschky, regional sales director Europe of Adherence & Delivery Systems at MWV Healthcare Packaging, said: “The PFP N meets our customers’ needs for a customizable solution that protects formula integrity and ultimately helps to ensure patient comfort and outcomes. The results of our physician survey validate that gentler, more natural applications are preferred by both healthcare providers and the patients they treat. PFP N will allow customers to achieve the therapeutic effect they want without preservatives.”